Learn More
Medchemexpress LLC Resminostat hydrochloride | 1187075-34-8 | 99.7% | 385.87 | 50 MG

Supplier: Medchemexpress LLC HY14718A50MG
Resminostat hydrochloride is a potent inhibitor of HDAC1, HDAC3, and HDAC6 (IC50 values: 42.5, 50.1, 71.8 nM, respectively), and a less potent inhibitor of HDAC8 (IC50: 877 nM). It is for research use only.
- Induces histone acetylation and inhibits myeloma cell growth.
- Displays substrate competitive binding (Ki: 27 nM).
- Modulates bcl-2 proteins and inhibits Akt pathway signalling.
- Synergistic with other anti-myeloma agents.
- Inhibits HNSCC cell growth (IC50s: 0.775-1.572 μM).
- Synergistic effect with irradiation on HNSCC cells.
- Reduces HCC cell viability with AZD-2014 co-treatment.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.